Evidence to date: ranibizumab and its potential in the treatment of retinopathy of prematurity

Evidence to date: ranibizumab and its potential in the treatment of retinopathy of prematurity

Samir N Patel, Michael A KlufasThe Retina Service of Wills Eye Hospital, Mid Atlantic Retina, Thomas Jefferson University, Philadelphia, PA, USACorrespondence: Michael A KlufasThe Retina Service of Wills Eye Hospital, Thomas Jefferson University, 840 Walnut Street, Suite 1020, Philadelphia, PA 19107...

Full description

Bibliographic Details
Main Authors: Patel SN, Klufas MA
Format: Article
Language:English
Published: Dove Medical Press 2019-08-01
Series:Eye and Brain
Subjects:
retinopathy of prematurity
ranibizumab
bevacizumab
Lucentis
Avastin
vascular endothelial growth factor
RAINBOW
BEAT-ROP
anti-VEGF
Online Access:https://www.dovepress.com/evidence-to-date-ranibizumab-and-its-potential-in-the-treatment-of-ret-peer-reviewed-article-EB

Internet

https://www.dovepress.com/evidence-to-date-ranibizumab-and-its-potential-in-the-treatment-of-ret-peer-reviewed-article-EB

Similar Items